Hemics wins Investors Forum
November 23, 2017
At the Dutch Life Sciences conference, Petra van den Elsen MD, PhD, MBA, CEO of Hemics B.V. pitched their business plan to a group of life science investors.
November 23, 2017
At the Dutch Life Sciences conference, Petra van den Elsen MD, PhD, MBA, CEO of Hemics B.V. pitched their business plan to a group of life science investors.
November 22, 2017
Data supporting Phase III development of KH176 in mitochondrial disease
November 22, 2017
Today at the Dutch Life Sciences Conference 2017, Chrétien Herben, director of the LifeSciences@Work Accelerator, announced Cyclomics as winning team of the 18th edition of the Venture Challenge.
November 16, 2017
Results of Phase 2 clinical trial with KH176 in adult mitochondrial disease patients will be presented at Dutch Life Sciences conference.
November 15, 2017
Visit two of the companies that are making Pivot Park the hotspot for pharmaceutical innovation.
October 19, 2017
Students will get the opportunity to be informed about the developments in the industry and to meet representatives from the companies and organisations.
October 12, 2017
Top Sector Life Sciences & Health presents new Knowledge and Innovation Agenda: Grow~Motion
October 04, 2017
ABN AMRO and its networks on the Bio Science Parks in Leiden and Amsterdam.